ALDEYRA THERAPEUTICS
Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are first-in-class potential treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sjögren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.
ALDEYRA THERAPEUTICS
Industry:
Biotechnology Developer Platform Health Care Therapeutics
Founded:
2004-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.aldeyra.com
Total Employee:
11+
Status:
Active
Contact:
(646) 536-7009
Email Addresses:
[email protected]
Total Funding:
287.39 M USD
Technology used in webpage:
IPv6 Gravity Forms DigiCert SSL Akamai Hosted RapidSSL IHS Markit
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-29 | Helio Vision | Helio Vision acquired by Aldeyra Therapeutics | 25 M USD |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Aldeyra Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-28 | Aldeyra Therapeutics Announces Chief Financial Officer Transition |
Official Site Inspections
http://www.aldeyra.com Semrush global rank: 7.49 M Semrush visits lastest month: 758
- Host name: 42.57.196.35.bc.googleusercontent.com
- IP address: 35.196.57.42
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Aldeyra Therapeutics"
Aldeyra Therapeutics - Crunchbase Company Profile & Funding
Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. …See details»
About Aldeyra Therapeutics | Aldeyra Pharmaceuticals, …
Aldeyra’s Mission At Aldeyra, we are devoted to developing medications to enhance the well-being of patients dealing with immune-mediated and metabolic illnesses. Our portfolio of product candidates are designed to target the …See details»
Aldeyra Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Aldeyra Therapeutics says its small-molecule RASP modulator reproxalap has succeeded in a new Phase III dry-eye disease trial as its plots a second attempt at securing FDA approval …See details»
SEC Filing | Aldeyra Therapeutics, Inc.
ALDEYRA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) ... incorporation or organization) (I.R.S. Employer. Identification No.) 131 Hartwell Avenue, Suite …See details»
Aldeyra Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Aldeyra Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Company Aldeyra Therapeutics, Inc. - MarketScreener.com
Aug 31, 2005 Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product …See details»
Aldeyra Therapeutics, Inc. - VentureRadar
At Aldeyra, we’re a pioneer in the development of medicines to improve the lives of patients with immune-mediated diseases. Our pipeline of drug candidates is focused on inhibiting …See details»
Aldeyra Therapeutics - Contacts, Employees, Board Members, …
Organization. Aldeyra Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Aldeyra Therapeutics has 3 current …See details»
Todd C. Brady, M.D., Ph.D. - Aldeyra Therapeutics, Inc.
Dr. Brady has served as the President and Chief Executive Officer of Aldeyra since 2012 and as a member of our board of directors since 2005. Prior to Aldeyra, Dr. Brady served as …See details»
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application …
LEXINGTON, Mass., October 03, 2024--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed …See details»
Aldeyra Therapeutics - Overview, News & Similar companies
Apr 25, 2024 Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024 LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) …See details»
ORGANIZATION AND COMPOSITION - Aldeyra Therapeutics, Inc.
ORGANIZATION AND COMPOSITION The members of the Committee will be nominated by, will be appointed by, and will serve at the discretion of, the Board and will consist of at least two …See details»
Aldeyra Therapeutics Enters into Exclusive Option Agreement with …
Nov 1, 2023 LEXINGTON, Mass.--(BUSINESS WIRE)--Nov. 1, 2023-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and …See details»
Leadership and Board of Directors - Aldeyra Therapeutics, Inc.
Dr. Bronstein joined the Aldeyra board of directors in 2010, and is an independent consultant to companies in the life science industry. Prior to his consulting role, he was Executive Vice …See details»
Aldeyra Therapeutics - Funding, Financials, Valuation & Investors
Aldeyra Therapeutics is registered under the ticker NASDAQ:ALDX . Their stock opened with $8.00 in its May 5, 2014 IPO. Aldeyra Therapeutics is funded by Hercules Capital. Aldeyra …See details»
Aldeyra Therapeutics, Inc. (ALDX) - Stock Analysis
May 2, 2014 Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is …See details»
Aldeyra Therapeutics - Craft
Oct 7, 2024 Aldeyra Therapeutics is a biotechnology company focused primarily on the development of new products for immune-mediated, inflammatory, orphan and other diseases …See details»
Aldeyra Therapeutics Inc, ALDX:NAQ profile - FT.com - Financial …
Dec 10, 2024 Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product …See details»
Aldeyra Therapeutics Announces Collaboration With the National ...
Has not been approved for sale in the U.S. or elsewhere. www.aldeyra.com About the National Organization for Rare Disorders Established in 1983 by patient organization leaders providing …See details»